139 related articles for article (PubMed ID: 35473671)
1. Lifetime ovulations and epithelial ovarian cancer risk and survival: A systematic review and meta-analysis.
Fu Z; Taylor S; Modugno F
Gynecol Oncol; 2022 Jun; 165(3):650-663. PubMed ID: 35473671
[TBL] [Abstract][Full Text] [Related]
2. Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis.
Fu Z; Brooks MM; Irvin S; Jordan S; Aben KKH; Anton-Culver H; Bandera EV; Beckmann MW; Berchuck A; Brooks-Wilson A; Chang-Claude J; Cook LS; Cramer DW; Cushing-Haugen KL; Doherty JA; Ekici AB; Fasching PA; Fortner RT; Gayther SA; Gentry-Maharaj A; Giles GG; Goode EL; Goodman MT; Harris HR; Hein A; Kaaks R; Kiemeney LA; Köbel M; Kotsopoulos J; Le ND; Lee AW; Matsuo K; McGuire V; McLaughlin JR; Menon U; Milne RL; Moysich KB; Pearce CL; Pike MC; Qin B; Ramus SJ; Riggan MJ; Rothstein JH; Schildkraut JM; Sieh W; Sutphen R; Terry KL; Thompson PJ; Titus L; van Altena AM; White E; Whittemore AS; Wu AH; Zheng W; Ziogas A; Taylor SE; Tang L; Songer T; Wentzensen N; Webb PM; ; Risch HA; Modugno F
J Natl Cancer Inst; 2023 May; 115(5):539-551. PubMed ID: 36688720
[TBL] [Abstract][Full Text] [Related]
3. Lifetime number of ovulatory cycles and epithelial ovarian cancer risk in African American women.
Peres LC; Moorman PG; Alberg AJ; Bandera EV; Barnholtz-Sloan J; Bondy M; Cote ML; Funkhouser E; Peters ES; Schwartz AG; Terry PD; Abbott SE; Camacho F; Wang F; Schildkraut JM
Cancer Causes Control; 2017 May; 28(5):405-414. PubMed ID: 28251458
[TBL] [Abstract][Full Text] [Related]
4. Relationship between lifetime ovulatory cycles and overexpression of mutant p53 in epithelial ovarian cancer.
Schildkraut JM; Bastos E; Berchuck A
J Natl Cancer Inst; 1997 Jul; 89(13):932-8. PubMed ID: 9214672
[TBL] [Abstract][Full Text] [Related]
5. Offspring sex and risk of epithelial ovarian cancer: a multinational pooled analysis of 12 case-control studies.
Modugno F; Fu Z; Jordan SJ; Group A; Chang-Claude J; Fortner RT; Goodman MT; Moysich KB; Schildkraut JM; Berchuck A; Bandera EV; Qin B; Sutphen R; McLaughlin JR; Menon U; Ramus SJ; Gayther SA; Gentry-Maharaj A; Karpinskyj C; Pearce CL; Wu AH; Risch HA; Webb PM
Eur J Epidemiol; 2020 Nov; 35(11):1025-1042. PubMed ID: 32959149
[TBL] [Abstract][Full Text] [Related]
6. Alcohol drinking and epithelial ovarian cancer risk. a systematic review and meta-analysis.
Rota M; Pasquali E; Scotti L; Pelucchi C; Tramacere I; Islami F; Negri E; Boffetta P; Bellocco R; Corrao G; La Vecchia C; Bagnardi V
Gynecol Oncol; 2012 Jun; 125(3):758-63. PubMed ID: 22449732
[TBL] [Abstract][Full Text] [Related]
7. Luteinising hormone releasing hormone (LHRH) agonists for the treatment of relapsed epithelial ovarian cancer.
Wuntakal R; Seshadri S; Montes A; Lane G
Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD011322. PubMed ID: 27356090
[TBL] [Abstract][Full Text] [Related]
8. Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk: Evidence from the Ovarian Cancer Association Consortium.
Cannioto R; LaMonte MJ; Risch HA; Hong CC; Sucheston-Campbell LE; Eng KH; Brian Szender J; Chang-Claude J; Schmalfeldt B; Klapdor R; Gower E; Minlikeeva AN; Zirpoli GR; Bandera EV; Berchuck A; Cramer D; Doherty JA; Edwards RP; Fridley BL; Goode EL; Goodman MT; Hogdall E; Hosono S; Jensen A; Jordan S; ; Kjaer SK; Matsuo K; Ness RB; Olsen CM; Olson SH; Leigh Pearce C; Pike MC; Anne Rossing M; Szamreta EA; Thompson PJ; Tseng CC; Vierkant RA; Webb PM; Wentzensen N; Wicklund KG; Winham SJ; Wu AH; Modugno F; Schildkraut JM; Terry KL; Kelemen LE; Moysich KB
Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1114-24. PubMed ID: 27197285
[TBL] [Abstract][Full Text] [Related]
9. The Risk of Ovarian Cancer Increases with an Increase in the Lifetime Number of Ovulatory Cycles: An Analysis from the Ovarian Cancer Cohort Consortium (OC3).
Trabert B; Tworoger SS; O'Brien KM; Townsend MK; Fortner RT; Iversen ES; Hartge P; White E; Amiano P; Arslan AA; Bernstein L; Brinton LA; Buring JE; Dossus L; Fraser GE; Gaudet MM; Giles GG; Gram IT; Harris HR; Bolton JH; Idahl A; Jones ME; Kaaks R; Kirsh VA; Knutsen SF; Kvaskoff M; Lacey JV; Lee IM; Milne RL; Onland-Moret NC; Overvad K; Patel AV; Peters U; Poynter JN; Riboli E; Robien K; Rohan TE; Sandler DP; Schairer C; Schouten LJ; Setiawan VW; Swerdlow AJ; Travis RC; Trichopoulou A; van den Brandt PA; Visvanathan K; Wilkens LR; Wolk A; Zeleniuch-Jacquotte A; Wentzensen N;
Cancer Res; 2020 Mar; 80(5):1210-1218. PubMed ID: 31932455
[TBL] [Abstract][Full Text] [Related]
10. Breastfeeding and ovarian cancer risk: a meta-analysis of epidemiologic studies.
Luan NN; Wu QJ; Gong TT; Vogtmann E; Wang YL; Lin B
Am J Clin Nutr; 2013 Oct; 98(4):1020-31. PubMed ID: 23966430
[TBL] [Abstract][Full Text] [Related]
11. Feto-maternal outcomes of pregnancy complicated by epithelial ovarian cancer: a systematic review of literature.
Blake EA; Kodama M; Yunokawa M; Ross MS; Ueda Y; Grubbs BH; Matsuo K
Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():97-105. PubMed ID: 25668134
[TBL] [Abstract][Full Text] [Related]
12. Estimated Number of Lifetime Ovulatory Years and Its Determinants in Relation to Levels of Circulating Inflammatory Biomarkers.
Huang T; Shafrir AL; Eliassen AH; Rexrode KM; Tworoger SS
Am J Epidemiol; 2020 Jul; 189(7):660-670. PubMed ID: 31845729
[TBL] [Abstract][Full Text] [Related]
13. Pegylated liposomal doxorubicin for first-line treatment of epithelial ovarian cancer.
Lawrie TA; Rabbie R; Thoma C; Morrison J
Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD010482. PubMed ID: 24142521
[TBL] [Abstract][Full Text] [Related]
14. Lifetime ovulatory cycles and ovarian cancer risk in 2 Italian case-control studies.
Pelucchi C; Galeone C; Talamini R; Bosetti C; Montella M; Negri E; Franceschi S; La Vecchia C
Am J Obstet Gynecol; 2007 Jan; 196(1):83.e1-7. PubMed ID: 17240246
[TBL] [Abstract][Full Text] [Related]
15. Invited Commentary: Relationship Between Ovulation and Markers of Systemic Inflammation Versus Markers of Localized Inflammation.
Schildkraut JM
Am J Epidemiol; 2020 Jul; 189(7):671-673. PubMed ID: 31845738
[TBL] [Abstract][Full Text] [Related]
16. Postoperative hormone replacement therapy for epithelial ovarian cancer patients: a systematic review and meta-analysis.
Li D; Ding CY; Qiu LH
Gynecol Oncol; 2015 Nov; 139(2):355-62. PubMed ID: 26232517
[TBL] [Abstract][Full Text] [Related]
17. Lifetime Number of Ovulatory Cycles and Risks of Ovarian and Endometrial Cancer Among Postmenopausal Women.
Yang HP; Murphy KR; Pfeiffer RM; George N; Garcia-Closas M; Lissowska J; Brinton LA; Wentzensen N
Am J Epidemiol; 2016 May; 183(9):800-14. PubMed ID: 27190045
[TBL] [Abstract][Full Text] [Related]
18. Relationship between number of ovulatory cycles and accumulation of mutant p53 in epithelial ovarian cancer.
Webb PM; Green A; Cummings MC; Purdie DM; Walsh MD; Chenevix-Trench G
J Natl Cancer Inst; 1998 Nov; 90(22):1729-34. PubMed ID: 9827528
[TBL] [Abstract][Full Text] [Related]
19. Does risk for ovarian malignancy algorithm excel human epididymis protein 4 and CA125 in predicting epithelial ovarian cancer: a meta-analysis.
Li F; Tie R; Chang K; Wang F; Deng S; Lu W; Yu L; Chen M
BMC Cancer; 2012 Jun; 12():258. PubMed ID: 22712526
[TBL] [Abstract][Full Text] [Related]
20. Dynamics of the primate ovarian surface epithelium during the ovulatory menstrual cycle.
Wright JW; Jurevic L; Stouffer RL
Hum Reprod; 2011 Jun; 26(6):1408-21. PubMed ID: 21421660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
